Strati P, Agajanian R, Lossos IS, Coleman M, et al. Acalabrutinib in combination with rituximab and lenalidomide in patients with relapsed or refractory follicular lymphoma: Results of the phase 1b open-label study (ACE-LY-003). Br J Haematol 2024 Dec 12. doi: 10.1111/bjh.19951.
PMID: 39667721